INSULIN HUMAN and DYSPNOEA

1,273 reports of this reaction

1.5% of all INSULIN HUMAN reports

#9 most reported adverse reaction

Overview

DYSPNOEA is the #9 most commonly reported adverse reaction for INSULIN HUMAN, manufactured by Eli Lilly and Company. There are 1,273 FDA adverse event reports linking INSULIN HUMAN to DYSPNOEA. This represents approximately 1.5% of all 82,903 adverse event reports for this drug.

Patients taking INSULIN HUMAN who experience dyspnoea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

DYSPNOEA1,273 of 82,903 reports

DYSPNOEA is a less commonly reported adverse event for INSULIN HUMAN, but still significant enough to appear in the safety profile.

Other Side Effects of INSULIN HUMAN

In addition to dyspnoea, the following adverse reactions have been reported for INSULIN HUMAN:

BLOOD GLUCOSE INCREASED — 10,559 reports
BLOOD GLUCOSE DECREASED — 3,452 reports
DRUG INEFFECTIVE — 3,143 reports
INCORRECT DOSE ADMINISTERED — 2,163 reports
HYPOGLYCAEMIA — 1,533 reports
NAUSEA — 1,469 reports
VISUAL IMPAIRMENT — 1,463 reports
WEIGHT DECREASED — 1,306 reports
FALL — 1,243 reports
MALAISE — 1,177 reports

Other Drugs Associated with DYSPNOEA

The following drugs have also been linked to dyspnoea in FDA adverse event reports:

0XYGEN ABEMACICLIB ABIRATERONE ACETATE ACALABRUTINIB ACETAMINOPHEN ACETAMINOPHEN 325 MG ACETAMINOPHEN 325MG ACETAMINOPHEN 500 MG ACETAMINOPHEN 500MG ACETAMINOPHEN AND CODEINE PHOSPHATE ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE ACETAMINOPHEN AND PHENYLEPHRINE HYDROCHLORIDE ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL ACETAMINOPHEN, DEXTROMETHORPHAN HBR ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCL ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL ACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE

Frequently Asked Questions

Does INSULIN HUMAN cause DYSPNOEA?

DYSPNOEA has been reported as an adverse event in 1,273 FDA reports for INSULIN HUMAN. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is DYSPNOEA with INSULIN HUMAN?

DYSPNOEA accounts for approximately 1.5% of all adverse event reports for INSULIN HUMAN, making it a notable side effect.

What should I do if I experience DYSPNOEA while taking INSULIN HUMAN?

If you experience dyspnoea while taking INSULIN HUMAN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

INSULIN HUMAN Full Profile All Drugs Causing DYSPNOEA Eli Lilly and Company Drugs

Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.